+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Effect of suiphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy



Effect of suiphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy



Nephrology Dialysis Transplantation 11(1): 182-185




(PDF emailed within 0-6 h: $19.90)

Accession: 062527497

Download citation: RISBibTeXText

DOI: 10.1093/oxfordjournals.ndt.a027038


Related references

Effect of sulphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy. Nephrology, Dialysis, Transplantation 11(1): 182-185, 1996

Determination of albuminuria in type 1 and type 2 diabetic patients with microproteinuria and overt nephropathy comparative evaluation between a radial immunodiffusion procedure and a highly sensitive radioimmunoassay. Ricerca in Clinica e in Laboratorio 17(2): 171-179, 1987

Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy. Journal of the American Society of Nephrology 27(11): 3459-3468, 2016

Effect of PF-04634817, an Oral CCR2/5 Chemokine Receptor Antagonist, on Albuminuria in Adults with Overt Diabetic Nephropathy. Kidney International Reports 3(6): 1316-1327, 2018

Does smoking increase the risk of progression of nephropathy and/or cardiovascular disease in type 2 diabetic patients with albuminuria and those without albuminuria?. American Journal of Cardiovascular Disease 6(2): 66-69, 2016

Effects of diet-therapy on urinary protein excretion albuminuria and renal haemodynamic function in obese diabetic patients with overt nephropathy. International Journal of Obesity 13(2): 203-211, 1989

Effect of thiazolidinedione treatment on proteinuria and renal hemodynamic in type 2 diabetic patients with overt nephropathy. Hormone and Metabolic Research 44(12): 914-918, 2013

Control of albuminuria in overt diabetic nephropathy: durability counts. Nephrology, Dialysis, Transplantation 31(9): 1371-1373, 2016

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Annals of Internal Medicine 138(7): 542-549, 1 April, 2003

Effect of antihypertensive combinations on arterial pressure, albuminuria, and glycemic control in patients with type II diabetic nephropathy: a randomized study. Nefrologia 22(2): 170-178, 2002

Near-normotension and near-normoglycemia in blind type I diabetic patients with overt diabetic nephropathy. Journal of Diabetic Complications 4(4): 179-183, 1990

Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy. Diabetes Care 29(5): 1024-1030, 2006

No association between the MTHFR gene polymorphism and diabetic retinopathy in type 2 diabetic patients without overt nephropathy. Diabetes Care 26(6): 1947-8; Author Reply 1948, 2003

Presence of retinopathy predicts more advanced diabetic nephropathy lesions in Japanese type 2 diabetic patients despite degree of albuminuria. Journal of the American Society of Nephrology 10(PROGRAM AND ABSTR ISSUE): 134A, Sept, 1999

The glucagon-like peptide-1 receptor agonist, liraglutide, attenuates the progression of overt diabetic nephropathy in type 2 diabetic patients. Tohoku Journal of Experimental Medicine 231(1): 57-61, 2014